
Consider buying NVIDIA (NVDA), as strong AI demand and its ability to sell in China could push the stock towards a $200-$300 price target. Another compelling opportunity is Pinduoduo (PDD), driven by huge traffic growth on its international Temu platform. Conversely, the entire Quantum Computing sector is viewed as a high-conviction short, with specific companies like IonQ (INQ) and D-Wave Quantum (QBTS) expected to fall. The case for shorting biotech firm Anavex Life Sciences (AVXL) is also considered conclusive due to dilution risk. Finally, Sarepta Therapeutics (SRPT) is a potential buy, as the stock may have already hit its bottom.

By @realmartinshkreli
Investing, music, science, math, technology, programming, medicine and more!